Maximo Santos
Primary Care · Long Beach, CANPI 1841620424
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.6% of the total across 184 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 14 manufacturers reported payments, led by Gilead at 52.1% of the total. Among primary care clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 184 payments — averaging $25.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gilead$2K
- Viiv Healthcare Company$2K
- EMD Serono, Inc.$119
- Amarin Pharma, Inc.$93
- Theratechnologies Inc.$78
- Johnson & Johnson$55
- plus $266 from 8 others
What the payments were for
- Speaking & faculty fees$180%
- Food & beverage$4,622100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gilead | 92 | $2,418 |
| Viiv Healthcare Company | 66 | $1,611 |
| EMD Serono, Inc. | 5 | $119 |
| Amarin Pharma, Inc. | 4 | $93 |
| Theratechnologies Inc. | 3 | $78 |
| Johnson & Johnson | 2 | $55 |
| Hologic Sales And Service, LLC | 2 | $48 |
| Pfizer | 2 | $44 |
| Napo Pharmaceuticals Inc | 2 | $42 |
| Merck | 2 | $36 |
| Axsome Therapeutics, Inc. | 1 | $27 |
| AbbVie | 1 | $27 |
| Braeburn Inc. | 1 | $22 |
| Exact Sciences | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,639 in reported general payments places this provider in the 90th percentile of 706 primary care providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BiktarvyBictegrav/Emtricit/Tenofov Ala | 40 | $161,045 |
| DescovyEmtricitabine/Tenofov Alafenam | 17 | $36,064 |
| JardianceEmpagliflozin | 11 | $8,317 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 27 | $881 |
| Atorvastatin Calcium | 86 | $588 |
| Gabapentin | 32 | $406 |
| Duloxetine Hcl | 19 | $395 |
| Metoprolol Succinate | 17 | $342 |
| Tamsulosin Hcl | 15 | $329 |
| Losartan Potassium | 37 | $321 |
| Amlodipine Besylate | 56 | $313 |
| Doxycycline Hyclate | 17 | $235 |
| Pravastatin Sodium | 11 | $184 |
| FenofibrateFenofibrate Nanocrystallized | 13 | $183 |
| Omeprazole | 25 | $138 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GileadBiktarvy, Descovy | $2,418 | $197,10857 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 706 primary care providers in California.
Other primary care in Long Beach
- Vanessa LeeLong Beach$16K
- Leslie FletcherTorrance$1.8M
- Hamideh PourzandLos Angeles$103K
- Veronica RamirezSacramento$83K
- Tyson FieldstedBakersfield$65K
- Kathryn CooperSan Diego$31K
- Shalaine Corbillala Mesa$22K
- Paula StoddardHanford$22K
- Ashley LoweSan Diego$19K
- Lynda TranHuntington Beach$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.